Private label desloratadine coming
This article was originally published in The Tan Sheet
Executive Summary
Perrigo may launch a desloratadine anti-allergy product in July 2012 or sooner under circumstances outlined in a recent Hatch-Waxman litigation settlement, the Allegan, Mich.-based private labeler announced Dec. 4. The allergy product is equivalent to Schering-Plough's Clarinex 5 mg tablets, which Wolters Kluwer estimates sold $300 million in the 12 months ending October 2008, Perrigo says. The firm says it may launch the product as a prescription or OTC product depending on its status at the time of the launch